Immune to Limitations

Armed with Deep Expertise in Immunology, We Are Up to the Challenge

happy surfers

About VBI

We are a company driven by immunology in the pursuit of powerful prevention and treatment of disease

Our vision is to stimulate and amplify the human immune system to target and overcome significant infectious diseases and aggressive cancers

Our belief in the importance of protecting and enhancing human life is at the core of everything we do

When properly stimulated, the human immune system is incredibly powerful and has profound potential. Because of their structural similarity to viruses presented in nature, virus-like particles (VLPs) are ideal for stimulating potent immune responses. Most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them a prime target for VBI’s proprietary enveloped virus-like particle (eVLP) platform technology.

VBI is a global biopharmaceutical company, with corporate headquarters in Cambridge, MA, United States, research and development facilities in Ottawa, Canada, and a research and manufacturing facility in Rehovot, Israel.

Jeff Baxter

Meet Our Team

Our team includes leaders and advisors with extensive immunology, vaccine development, medical, commercial, and industry expertise.

For us, this fight is personal, and we all share an unyielding determination to bring innovation to the prevention and treatment of disease.

Learn Moreabout our teamArrow
people meeting for the first tijme

Our Partnerships

At VBI, we believe that it takes the power of many great minds and organizations to solve the toughest challenges.

We value our partnerships with teams that share our philosophy and vision, and continue to seek meaningful collaborations across industry, government, and advocacy groups.

Learn Moreabout our partnershipsArrow
Go top